Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Grant or award Chief Executive Officer acquired 179,169 shares (grant or award)
  2. 4 Open-market sale Chief Medical Officer sold 2,177 shares at $10.62 ($23,120)
  3. 4 Open-market sale Chief Development Officer sold 176 shares at $10.62 ($1,869)
  4. 4 Grant or award Director acquired 9,459 shares (grant or award)
  5. 4 Grant or award Director acquired 9,459 shares (grant or award)
  6. 4 Grant or award Director acquired 9,459 shares (grant or award)
  7. 4 Grant or award Director acquired 9,459 shares (grant or award)
  8. 4 Grant or award Director acquired 9,459 shares (grant or award)
  9. 4 Grant or award Director acquired 9,459 shares (grant or award)
  10. 4 Grant or award Director acquired 9,459 shares (grant or award)
  11. 4 Grant or award Director acquired 9,459 shares (grant or award)
  12. 4 Open-market sale Chief Development Officer sold 177 shares at $8.71 ($1,542)
  13. 4 Grant or award Chief Medical Officer acquired 92,250 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Chief Development Officer sold 287 shares at $15.57 ($4,468)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award President and Head of R&D acquired 118,000 shares (grant or award)
  19. 4 Other disposition 10% owner disposed of 598,533 shares (other)
  20. 4 Other disposition Director disposed of 598,533 shares (other)

Page 8 of 16 · 301 filings